This paper reports an experiment designed to demonstrate that the calf lung can be sensitized to a specific respirable challenge following parenteral immunization with a nonliving antigen (human serum albumin). The possibility that immune-mediated injury could subsequently interfere with nonspecific mucosal defenses was also investigated by infecting calves with Pasteurella haemolytica after the antigen challenge and assessing pulmonary clearance of the organism. The results indicated that specific aerosol challenge produces reversible signs of respiratory hypersensitivity and that persistence of incidental infection in the upper respiratory tract is potentiated. Since the calves were sensitized by an immunization regime which imitated conventional vaccination, this study highlights the potential dangers of inactivated parenteral respiratory vaccines.
In common with other mucosal surfaces, the lung is capable of developing an immune response following local or systemic presentation of antigen. The subsequent response to specific challenge serves to protect the mucosal surface, but under certain conditions of sensitization the outcome appears to be harmful rather than beneficial. For example, Wilkie (16) demonstrated that hypersensitivity pneumonitis was produced in calves following repeated exposure to aerosols of Micropolyspora faeni whether or not they had been systemically primed. Furthermore, parenteral immunization of calves with killed Pasteurella haemolytica resulted in an increased incidence of pneumonic pasteurellosis at challenge (5) . Subsequent comparison of vaccination routes, using a killed culture of P. haemolytica, demonstrated that parenteral immunization was consistent with the development of pulmonary lesions at challenge, whereas local immunization was not (17) . In human medicine, pneumonitis resulting from occupational contact with airborne allergens is well documented and parenteral vaccination with inactivated organisms is known to have potentiated respiratory syncytial virus and Mycoplasma pneumoniae infections (3) . In the case of respiratory syncytial virus, it was proposed that high levels of circulating immunoglobulin G (IgG) antibody were induced in the absence of local humoral and cellular immunity, culminating in immune-mediated hypersensitivity at challenge (2) . This type of reaction is considered to be the consequence of complement activation and neutrophil influx following immune complex formation in the lower respiratory tract, which at its extreme is manifested clinically as pneumonitis (15) . In the case of vaccinepotentiated calf pasteurellosis, Wilkie et al. (17) proposed a different mechanism in which opsonization and phagocytosis of cytotoxic bacteria caused the death of macrophages, thus compromising lung defenses. They suggested that this process was enhanced by the absence of a local IgA antibody In addition to the local injury which results from immunemediated disease, the disruption of mucosal defenses may also predispose unrelated opportunist infections. A greater frequency of viral respiratory infections has been recorded in asthmatic children compared with their nonasthmatic siblings (12) , and in the pig hypersensitivity to food antigens in the gut has been shown to allow the proliferation of enteric pathogens (11) . The possibility exists, therefore, that immune-mediated lung disease in calves may be potentiated by parenteral vaccination with nonliving antigens and that subsequent mucosal hypersensitivity may permit opportunist infections.
We have previously shown that aerosol challenge with human serum albumin (HSA) in parenterally immunized calves caused an increase in the neutrophil population of free lung cells (14) . However, we did not observe clinical signs consistent with an immune-mediated inflammatory response. Since the duration of challenge was short (20 min) and only 4.2% of the aerosolized protein mass was concentrated within respirable particles (aerodynamic size, 0 to 3 ,um), we supposed that the challenge to the lower respiratory tract may have been insufficient to provoke inflammation to the point of hypersensitivity. Anti-P. haernolytica activity was evaluated by using the same assay system. An antigen extract of the organism was prepared by boiling a 48-h culture of the bacteria in brain heart infusion (Difco) and extracting the supernatant by centrifugation (8) . A 1:20 dilution of the supernatant was then used to coat the plates, and the assay was repeated as before.
Aerosol challenge. Calves inhaled a polydisperse liquid aerosol of HSA containing 248 mg of protein solution m3 of air for a period of 25 min. The aerosol was generated from a 0.5% solution of HSA in saline by an ultrasonic nebulizer (DeVilbiss model 65), and its characteristics were measured in real time, using an aerodynamic particle sizer (TSI Incorporated). Each calf inhaled an aerosol with an average mass median aerodynamic diameter of 5.7 pm (geometric standard deviation = 1.7). The antigen mass concentrated within respirable particles (<3.05 ,um) was on average 11.8% of the total generated by the nebulizer. Compared to our former study (14) , this represented an increase in the respirable antigen load by a factor of 2.8. To achieve this, turbulence and particle deposition within the system were reduced by increasing the diameter of the delivery ducting and reducing the linear flow of aerosol from 200 to 28 cm/s. The aerosol delivery system is illustrated in Fig. 1 .
The calves were challenged in two groups, A to D (group I) and E to H (group II). Group I animals were challenged on day 32 following the start of vaccination, when serum antibody titers wre shown to be high, and group II was challenged on day 39. At 24 h after challenge, each calf received an intrapulmonary inoculation of NARPH. All calves were rechallenged with HSA, using the same technique, on days 47 (group II) and 54 (group I).
On day 62 group I was subjected to a polydisperse liquid aerosol of 0.5% bovine serum albumin (Sigma) in saline solution to assess the effect of a nonspecific antigen challenge. In this instance the aerosol had an average mass median aerodynamic diameter of 6.25 p.m (geometric standard deviation = 1.7), and the protein mass concentrated within respirable particles was on average 7.7% of that generated by the nebulizer.
Clinical examination. Several clinical parameters were assessed at the time of aerosol challenge, on occasions during the 8 h thereafter, and once again 24 h later: (i) incidence of coughing; (ii) respiratory rate per minute (RR); (iii) dyspnea, defined here as respiratory distress featuring marked expiratory lift, head extension, and mouth breathing in addition to an increase in RR; (iv) rectal temperature; (v) demeanor, defined here as being alert or dull in nature (an alert calf demonstrated interest by getting up if recumbent and approaching an attendant; a dull calf was disinterested in the attendant and preferred recumbency even when encouraged to rise); (vi) appetite. All calves had been weaned at 6 weeks of age prior to aerosol exposure and calf nuts were fed only twice daily in addition to ad lib hay, so that a handful of nuts would normally be readily accepted at any time during the day. This act was therefore used as a criterion of appetite 5 to 6 h after challenge. Lung auscultation was attempted following aerosol challenge, but because of its subjective nature it was deemed unreliable as an indicator of underlying clinical pathology.
P. haemolytica infection and clearance studies. The P.
haemolytica type Al used in the experiment had been isolated from the lung of a pneumonic calf and was kindly donated by N. J. L. Gilmour of the Moredun Research Institute. Nalidixic acid resistance was induced after two subcultures, and the final strain was grown up in nutrient broth (Oxoid) and stored in 4-ml aliquots at -70°C. This culture was used to seed 200 ml of nutrient broth number II (Lab M) the day before the calves were infected. P. haemolytica in the 20-h broth was centrifuged (700 x g) for 12 min and suspended in 60 ml of sterile saline, giving a final concentration of 1.15 x 108 CFU/ml. Each calf received 10 ml of the suspension into the lower respiratory tract followed by 20 ml of saline. The inoculum was delivered through a 4-mm (outer diameter) sterile perspex tube introduced through the nasal cavity to a distance of 60 to 80 cm from the external nares.
For the purpose of assessing bacterial clearance following infection, it was assumed that reduced clearance within the lower lungs of compromised calves would result in an increased bacterial load being carried up the mucociliary escalator. This load was quantified by laryngeal swabbing at regular intervals for up to 56 h after infection. Swabs, 30 cm (Medical Wire and Equipment Co. Ltd.), were passed through the ventral meatus to the back of the nasopharynx and positioned in the larynx as the calf attempted to swallow, at which time the calf produced a faint roar on breathing. The swab was left in this position for 30 s.
To quantify the bacteria sampled, each swab tip was placed in a bijou containing 4 ml of 1:4-strength Ringer solution with glass beads and mixed on a Vortex mixer. The suspension was serially diluted and plated out onto 6% horse blood agar (Lab M blood agar base) with and without nalidixic acid (50 jig/ml). The plates were incubated aerobically at 37°C for 28 h, and the colonies were counted by the method of Miles et al. (10) .
Postmortem studies. All calves were slaughtered during the period 67 to 69 days following the start of vaccination, equivalent to 28 to 35 days postinfection with NARPH. Immediately after death, each calf was bled out and the larynx, trachea, and lungs were removed intact. The distribution of residual NARPH within the respiratory tract was determined by culturing swabs taken at seven selected sites between the upper and lower respiratory tracts in each calf. Gross lung pathology was compared between calves as reported previously (7) . Briefly, macroscopic lesions in each lung were scored out of 10 Before challenge, there was no significant difference between the RRs recorded in sham-immunized and immunized calves (Fig. 3) . During the aerosolization period the RR was assessed at 5, 10, and 20 min (mean plots are shown in Fig.  3 creases from prechallenge levels in both sham-immunized and immunized calves (P < 0.01; df = 14 in each case). However, in immunized calves the response was greater than in sham-immunized animals (P < 0.05; df = 22). In the 0-to 8- Changes in rectal temperatures from prechallenge values were less consistent (Fig. 4) Fig. 6 and Table 2 . Again, despite a lapse between the second challenges of groups I and II (days 54 and 47, respectively), the clinical findings were essentially the same and are recorded together.
Before aerosolization, there was no significant difference between the RRs recorded in sham-immunized and immunized calves (Fig. 6) . During challenge the RRs recorded at 5, 10, and 20 min indicated significant increases above prechallenge levels in immunized calves only (mean plots are shown in Fig. 6 at time zero: P < 0.01; df = 14). In the 0-to 8-h period following challenge, all immunized calves demonstrated RRs which exceeded those observed at each time point for sham-immunized calves A, G, and E. During the period 2 to 5 h these differences were significant (P < 0.05; df = 5 at each of four time points). A fourth sham-immunized calf (D) began with a prechallenge rate of 78 per min, having developed a chronically high RR, presumably as a result of P. haemolytica infection. This rate showed no tendency to increase during the postchallenge period, but it was excluded from the statistical comparison with immunized calves. By 24 h the RRs of all sham-immunized calves were no greater than either prechallenge or challenge levels, whereas those of immunized calves still exceeded their prechallenge levels (P < 0.05; df = 6).
Despite more frequent recording of rectal temperatures during 0 to 8 h postchallenge, there was no significant difference between sham-immunized and immunized calves at any time point. The data are not presented.
During the second aerosol challenge a greater incidence of coughing was recorded in all calves (Table 2 ). In immunized calves the incidence was significantly greater than in shamimmunized controls (P < 0.05; df = 6). Unlike the first challenge, only one of the four immunized calves (C) displayed a dull demeanor and poor appetite at 5 h despite increases in RR. The isolation of NARPH by nasolaryngeal swabbing was resumed in all calves following the second HSA challenge. All demonstrated a transient rise in the numbers isolated, which peaked between 6 and 12 h and returned to prechallenge levels by 18 h. Again, no significant difference was discerned between sham-immunized and immunized calves. Rectal temperatures did not rise significantly nor differ between the groups during the period of swabbing. The data are not presented.
Challenge with bovine serum albumin aerosol. Since the immunized calves of group I (B and C) had shown such a high incidence of coughing during the second HSA challenge (Table 2) , this group was subjected to an aerosol challenge of 0.5% bovine serum albumin for 25 min 8 days later (day 62), to ensure that the effect was not due to nonspecific aerosol irritation. A total of three coughs were then recorded during aerosolization of sham-immunized calves A and D, but none were recorded in the immunized pair. In addition, the 0-to 8-h RRs in the immunized pair showed no tendency to exceed those of the controls (Fig. 7) , in contrast to previous challenges with specific antigen (Fig. 3 and 6) .
Live weight gains. No significant difference in individual weight gains was demonstrable between sham-immunized and immunized calves during the experimental period. The data are not presented.
Postmortem findings. Immediately after death NARPH was isolated with greater frequency from tissues of the upper respiratory tracts of immunized calves (Table 3) . However, lung scoring indicated no difference in the extent of gross lung lesions between the two populations. A marked feature of these gross lesions was discrete abscessation in one or the other of the diaphragmatic lobes in seven of the eight calves.
DISCUSSION
The short-term reversible responses of immunized calves to respirable aerosol challenge as indicated by increases in RR ( Fig. 3 and 6 ) and changes in demeanor and appetite (Table 1) suggest immune-mediated respiratory disease. The lack of such responses in sham-immunized calves demonstrates that the phenomenon is antigen specific. Experimental lung hypersensitivity has been reported in cattle on previous occasions, but the sensitizing regimes involved either multiple parenteral immunization (4) or multiple respiratory exposures (16) . In the current study the immunization procedure mimics conventional vaccination regimes inasmuch as parenteral injections of a nonliving antigen in adjuvant were given on two occasions at an interval of 2 weeks. The findings are therefore more relevant to vaccineinduced disease than previous reports of experimental hypersensitivity.
Using an identical immunization regime, we have already demonstrated that serum IgG antibody activity correlates with titers found in lung wash and that aerosol challenge with HSA causes an increase in the neutrophil population of free lung cells, but we were unable to demonstrate clinical signs of pneumonitis (14) . In the current study, we increased our respirable antigen load by a factor of 2.8 and subsequently provoked a clinical response. This indicates that hypersensitivity is as much a function of the respirable antigen load at challenge as the regime used for sensitization. One explanation for the difference in our results is that in this study higher levels of respirable antigen combined with IgG antibody in the lower respiratory tract to produce more immune complexes and in consequence a greater inflammatory response. However, we have not characterized the nature of the hypersensitivity response here; indeed, there seems to be more than one type involved.
The respiratory rates of immunized calves were significantly raised above those of controls during the first HSA challenge (P < 0.05; Fig. 3 (Fig. 2) . It is also interesting that calves C and F, which produced the highest recorded RRs after HSA challenge ( Fig. 3 and 6 ), produced the most consistent upper respiratory tract isolates and the highest lung scores (Table 3 ). In a small study such as this the evidence is necessarily scant, but it does suggest that, if the lung becomes sensitized, suitable conditions of challenge may render tissues more susceptible to colonization by the challenge organism or incidental opportunists. Against this, the only animal to display overt pneumonia following infection was sham-immunized calf D. This calf developed a persistently raised respiratory rate ( Fig. 6 and 7) and pro- Wilkie and colleagues (17) ascribed the adverse effects of killed parenteral P. haemolytica vaccines to alveolar macrophage cytotoxicity following specific opsonization and enhanced ingestion of toxigenic bacteria. While the importance of macrophage cytotoxicity in the pathogenesis of pasteurellosis is undeniable, the experiment reported here indicates that other adverse immune-mediated mechanisms may also be potentiated following parenteral vaccination. Furthermore, these changes were apparent after a challenge duration of only 25 min, and it is interesting to speculate what effect prolonged exposure would have had on the resulting pneumonitis. In a large field study, Martin et al. (9) found a positive correlation between increased mortality in cattle and the use of various types of respiratory vaccine; however, these were not exclusively inactivated vaccines nor were they all administered parenterally.
In conclusion, our results indicate the potential dangers of using nonliving parenteral vaccines in calves which will be exposed to high concentrations of respirable antigen challenge. Such conditions are likely to be a feature of overcrowding and poor environmental hygiene. Furthermore, if hypersensitivity to challenge is potentiated by the absence of a local response to parenteral vaccination (2), it is clearly desirable that respiratory vaccines promote local as well as systemic immunity. Local immunity is best achieved by mucosal presentation of antigen in a replicating form which is capable of colonizing the epithelium (1) . Commercial mucosal vaccines are invariably attenuated for field use, but this is not permissible when an organism may revert to virulence. In such cases the protective immunity afforded by local administration of the killed organism or its subunits should be investigated as an alternative to parenteral administration alone.
